Los Angeles Capital Management LLC Mei Pharma, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$0.54 - $2.74 $9,268 - $47,029	-17,164 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$2.33 - $3.37 $46,672 - $67,504	-20,031 Reduced 53.85%	17,164 $46,000
Q2 2021 Aug 05, 2021	SELL	$2.6 - $3.65 $5,200 - $7,300	-2,000 Reduced 5.1%	37,195 $106,000
Q1 2021 May 05, 2021	BUY	$2.73 - $4.5 $38,894 - $64,111	14,247 Added 57.11%	39,195 $134,000
Q4 2020 Feb 04, 2021	BUY	$2.6 - $3.32 $64,864 - $82,827	24,948 New	24,948 $66,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $366M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.